Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro

Cancer Research

Volumn 56, Issue 1, 1996, Pages 182-189

  Zagzag, David ^a   Friedlander, David R ^a   Dosik, Jonathan ^a   Chikramane, Sucheta ^a   Chan, Wai ^a   Greco, M Alba ^a   Allen, Jeffrey C ^a   Dorovini Zis, Katerina ^b   Grumet, Martin ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TENASCIN;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BRAIN BLOOD VESSEL; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGOLD STAINING; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; RNA PROBE; SILVER STAINING; TUMOR VASCULARIZATION;

ASTROCYTOMA; BASE SEQUENCE; BRAIN; BRAIN NEOPLASMS; ENDOTHELIUM; HUMANS; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TENASCIN;

EID: 0030070486     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Erickson, H. P Tenascin-C, tenascin-R, tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol., 5: 869-876, 1993.
2. Bourdon, M. A., Wikstrand, C. J., Furthmayr, H., Matthews, T. J., and Bigner, D D. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody Cancer Res., 43: 2796-2805, 1983.
3. McComb, R. D., and Bigner, D D. Immunolocalization of monoclonal antibody-defined extracellular matrix antigens in human brain tumors. J. Neurol. Oncol., 3: 181-186, 1985.
4. Higuchi, M , Ohnishi, T., Arita, N., Hiraga, S , and Hayakawa, T. Expression of tenascin in human gliomas, its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol., 85: 481-487, 1993.
5. Zagzag, D., Friedlander, D. R., Miller, D. C., Dosik, J., Cangiarella, J , Kostianovsky, M., Cohen, H., Grumet, M , and Greco, M. A Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res., 55. 907-914, 1995.
6. Grumet, M., Hoffman, S., Crossin, K L., and Edelman, G. M. Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc. Natl. Acad. Sci USA, 82: 8075-8079, 1985.
7. Brodkey, J A , Laywell, E. D., O'Brien, T. F., Faissner, A., Stefansson, K., Dorries, U., Schachner, M., and Steindler, D. A. Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J. Neurosurg., 82: 106-112, 1995.
8. McComb, R. D , and Miller, K. A. Developmental and reactive expression of tenascin (TN) in the human cerebellum. J. Neuropathol. Exp Neurol., 49: 344, 1990.
9. Dorries, U., Bartsch, U., Nolte, Ch., Roth, J., and Schachner, M Adaptation of a non-radioactive in situ hybridization method to electron microscopy: detection of tenascin mRNAs in mouse cerebellum with digoxigenin-labelled probes and gold-labelled antibodies. Histochemistry, 99: 251-262, 1993
10. Hardman, J The angioarchitecture of the gliomata. Brain. 63: 91-118, 1940.
11. Nystrom, S. Pathological changes in blood vessels of human glioblastoma multiforme. Acta Pathol. Microbiol. Scand , 49 (Suppl. 137): 1-83, 1960.
12. Brem, S , Cotran, R., and Folkman, J Tumor angiogenesis: a quantitative method for histologic grading. J. Natl. Cancer Inst., 48: 347-356, 1972.
13. Haddad, S. F , Moore, S. A., Schelper, R. L., and Goeken, J. A. Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures in glioblastoma multiforme J. Neuropathol. Exp. Neurol., 51: 488-492, 1992.
14. Wesseling, P., Schlingemann, R. O., Rietveld, F. J R , Link, M., Burger, P. C., and Ruiter, D. J. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immuno-light and immuno-electron microscopic study J. Neuropathol. Exp. Neurol., 54: 304-310, 1995.
15. Koukoulis, G. K., Gould, V. E., Bhattacharyya, A., Gould, J. E., Howeedy, A. A., and Virtanen, I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum. Pathol., 22: 636-643, 1991.
16. Webersinke, G., Bauer, H., Amberger, A., Zach, O., and Bauer, H C. Comparison of gene expression of extracellular matrix molecules in brain microvascular endothelial cells and astrocytes. Biochem. Biophys. Res. Commun., 189: 877-884, 1992.
17. Ramadori, G , Schwogler, S , Veit, Th., Rieder, H., Chiquet-Ehrismann, R., Mackie, E. J , and Meyer zum Buschenfelde, K-H Tenascin gene expression in rat liver and in rat liver cells. In vivo and in vitro studies. Virchows Archiv. B Cell Pathol., 60: 145-153, 1991.
18. Canfield, A.E , and Schor, A. M. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J. Cell Sci., 108, 797-809, 1995.
19. Hahn, A. W. A., Kern, F., Jonas, U., John, M., Bulher, F. R., Resink, T. J. Functional aspects of vascular tenascin-C expression. J. Vasc. Res., 32: 162-174, 1995.
20. Sharifi, B. G , LaFleur, D. W., Pirola, C. J., Forrester, J S., Fagin, J. A. Angiotesin II regulates tenascin gene expression in vascular smooth muscle cells J. Biol. Chem., 267: 23910-23915, 1992
21. Mackie, E. J , Scott-Burden, T., Hahn, A. W. A., Kern, F , Bernhardt, J., Regenass, S , Weller, A., and Buhler, F. R. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am. J. Pathol. 141: 377-388, 1992.
22. Schor, A M., Canfield, A E., Sloan, P., and Schor, S. L. Differentiation of pericytes in culture is accompanied by changes in the extracellular matrix. In Vitro Cell & Dev. Biol. 27A: 651-659, 1991
23. Nies, D E , Hemesath, T J , Kim, J.H., Gulcher, J. R., and Stefansson, K. The complete cDNA sequence of human hexabrachion (tenascin) A multidomain protein containing unique epidermal growth factor repeats. J. Biol Chem., 266. 2818-2823, 1991.
24. Dorovini-Zis, K., Prameya, R., and Bowman, P D. Culture and characterization of microvascular endothelial cells derived from human brain. Lab. Invest., 64: 425-436, 1991.
25. Huynh, H K., and Dorovini-Zis, K. Effects of interferon-γ on primary cultures of human brain microvessel endothelial cells. Am J Pathol., 142: 1265-1278, 1993
26. Grumet, M., Hoffman, S , and Edelman, G M. Two antigenically related neuronal cell adhesion molecules of different specificities mediate neuron-neuron and neuron-glia adhesion Proc. Natl. Acad Sci USA, 81: 267-271, 1984.
27. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets, procedures and some applications. Proc. Natl Acad. Sci. USA, 76. 4350-4354, 1979.
28. Rettig, W J., and Garin-Chesa, P. Cell type-specific control of human neuronectin secretion by polypeptide mediators and phorbol ester. J. Histochem. Cytochem., 37: 1777-1786, 1989.
29. Rettig, W J., Erickson, H. P., Albino, A P., and Garin-Chesa, P Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways J. Cell Sci., 107: 487-497, 1994
30. Adams-Pearson, C , Pearson, D., Shibahara, S., Hofsteenge, J., and Chiquet-Ehrismann, R. Tenascin, cDNA cloning and induction by TGF-β. EMBO J., 7. 2977-2982, 1988.
31. Meiners, S , Marone, M , Rittenhouse, J. L., and Geller, H. M. Regulation of astrocytic tenascin by basic fibroblast growth factor Dev. Biol., 160. 480-493, 1993
32. Tucker, R P , Hammarback, J. A., Jenrath, D A , Mackie, E J., and Xu, Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J. Cell Sci., 104: 69-76, 1993.
33. Zagzag, D. Angiogenic growth factors in neural embryogenesis and neoplasia. Am. J. Pathol , 146. 293-309, 1995.
34. Zagzag, D., Miller, D. C., Sato, Y., Rifkin, D. B., and Burstein, D. E. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res., 50: 7393-7398, 1990
35. Heimark, R. L., Twardak, D. R., and Schwartz, S. M Inhibition of endothelial regeneration by type-β transforming growth factor from platelets. Science (Washington DC), 233. 1078-1080, 1986
36. Frater-Schroder, M., Risau, W., Hallmann, R , Gautshi, P., and Bohlen, P. Tumor necrosis factor type α. a potent inhibitor of endothelial cell growth in vitro is angiogenic in vivo. Proc Natl. Acad. Sci. USA. 84: 5277-5281, 1987.
37. Roberts, A. B., Sporn, M B., Assoian, R. K., Smith, J M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V , Kehrl, J. H., and Fauci, A. S. Transforming growth factor type β. rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci USA, 83: 4167-4171, 1986.
38. Ferrara, N , and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161: 851-858, 1989
39. Prieto A. L., Andersson-Fisone, C., and Crossin, K. L Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin J Cell Biol., 119: 663-678, 1992.
40. Joshi, P , Chung, C. Y , Aukhil, I., and Erickson, H. P. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J. Cell Sci., 106: 389-400, 1993.
41. 3 integrins. J. Cell Sci., 105: 1001-1012, 1993.
42. Chung, C. Y., and Erickson, H. P. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C J Cell Biol., 126: 539-548, 1994.
43. Erickson, H. P., and Bourdon, M. A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol., 5: 71-92, 1989.
44. Mackie, E. J., Tucker, R. P. Halfter, W., Chiquet-Ehrismann, R., and Epperlein, H. H. The distribution of tenascin coincides with pathways of neural crest migration. Development (Camb.), 102: 237-230, 1988.
45. Spence, S. G., and Poole, T. J. Developing blood vessels and associated extracellular matrix as substrates for neural crest migration in Japanese quail. Coturnix coturnix japonica. Int. J. Dev. Biol., 38: 85-98, 1994.
46. r 220,000 isoform expression correlates with corneal cell migration. Development (Camb.), 112: 605-614, 1991.
47. Bronner-Fraser, M. Distribution and function of tenascin during cranial neural crest development in the chick J Neurosci Res, 21: 135-147, 1988
48. Murphy-Ullrich, J. E., Ligtner, V. A., Aukhil, I., Yan, Y. Z , Erickson, H. P., and Hook, M. Focal adhesion integrity is downregulated by the alternatively spliced domain of tenascin. J Cell Biol., 115: 1127-1136, 1991
49. Chung, C. Y., Pallero, M. A., Murphy-Ullrich, J. E., and Erickson, H. P. The disassembly of focal adhesions and the proliferation of endothelial cells induced by the interaction of tenascin with cell surface annexin II. Mol. Biol. Cell. 5: 311a, 1994.
50. Tan, S-S , Crossin, K. L., Hoffman, S., and Edelman, G. M. Asymmetric expression in somites of cytotactin and its proteoglycan ligand is correlated with neural crest cell distribution. Proc Natl. Acad. Sci USA, 84: 7977-7981, 1987.
51. Crossin, K. L. Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts Proc. Natl. Acad. Sci. USA, 88: 11403-11407, 1991.
52. Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., and Sakakura, T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis Cell, 47: 131-139, 1986.
53. Gospodarowicz, D., Brown, K. D., Birdwell, C. R., and Zetter, B. R. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor and thrombin. J. Cell Biol., 77: 774-788, 1978.
54. Ausprunk, D. H., and Folkman, J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res , 14: 52-65, 1977
55. Chuong, C-M., and Chen, H-M. Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am. J. Pathol., 138: 427-440, 1991
56. Mackie, E. J., Halfter, W., and Liverani, D Induction of tenascin in healing wounds. J Cell Biol., 107: 2757-2767, 1988
57. Marton, L. S , Gulcher, J. R., and Stefansson, K. Binding of hexabrachions to heparin and DNA. J. Biol. Chem., 264: 13145-13149, 1989.
58. Aukhil, I., Joshi, P., Yan, Y., and Erickson, H. P. Cell- and heparin- binding domains of the hexabrachion arm identified by tenascin expression proteins. J. Biol. Chem., 268: 2542-2553, 1993.
59. Folkman, J., and Shing, Y. Control of angiogenesis by heparin and other sulfated polysaccharides. Adv. Exp Med. Biol., 313: 355-364, 1992.
60. 3 for angiogenesis. Science (Washington DC), 264: 569-571, 1994
61. Scherer, H. J. The forms of growth in gliomas and their practical significance. Brain. 63: 1-35, 1940.
62. Zagzag, D., Brem, S., and Robert, F. Neovascularization and tumor growth in the rabbit brain a model for experimental studies of angiogenesis and the blood-brain barrier. Am. J Pathol., 131. 361-372, 1988.
63. Moscatelli, D., and Rifkin, D. B. Membrane and matrix localization of proteinases, a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys Acta, 948. 67-85, 1988.